Skip to main content

Table 2 Comparison between patients before and 12 weeks after EOT regarding APRI score, FIB-4 index, and FibroScan

From: Angiopoietin-2 as a predictor of fibrosis regression in chronic hepatitis C virus patients after direct-acting antiviral drugs

Variables

Before treatment

12 w after treatment

Test of significance

P

FibroScan (kPa)

Mean ±SD.

8.96±3.38

7.21±3.57

t = 9.937*

<0.001*

Range

2.50–16.30

1.0–15.40

FIB-4

Mean ±SD.

1.51±1.11

1.31±0.90

Z = 4.995*

<0.001*

Range

0.47–5.16

0.44–4.14

APRI Score

Mean ±SD.

0.47±0.40

0.38±0.32

Z = 4.445*

<0.001*

Range

0.20–1.90

0.10–1.50

  
  1. t paired t-test, Z Wilcoxon signed-ranks test, *significant